INDOLINONE DERIVATIVES AS PROTEIN KINASE/PHOSPHATASE INHIBITORS
申请人:Sugen, Inc.
公开号:EP1294688A2
公开(公告)日:2003-03-26
US6706709B2
申请人:——
公开号:US6706709B2
公开(公告)日:2004-03-16
US7071332B2
申请人:——
公开号:US7071332B2
公开(公告)日:2006-07-04
[EN] INDOLINONE DERIVATIVES AS PROTEIN KINASE/PHOSPHATASE INHIBITORS<br/>[FR] DERIVES D'INDOLINONE COMME INHIBITEURS DE PHOSPHATASE/PROTEINE KINASE
申请人:SUGEN INC
公开号:WO2001094312A2
公开(公告)日:2001-12-13
The present invention relates to certain 2-indolinone compounds which modulate the activity of protein kinases ('PKs') and phosphatases. The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
Indolinone derivatives as protein kinase/phosphatase inhibitors
申请人:——
公开号:US20020052369A1
公开(公告)日:2002-05-02
The present invention relates to certain 2-indolinone compounds which modulate the activity of protein kinases (“PKs”) and phosphatases. The compounds of this invention are therefore useful in treating disorders related to abnormal PK activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.